Скачать с ютуб Remdesivir treatment for Covid-19: New Drug Review. Veklury coronavirus antiviral from Gilead. в хорошем качестве

Remdesivir treatment for Covid-19: New Drug Review. Veklury coronavirus antiviral from Gilead.

New Drug Review: Remdesivir treatment for Covid-19 or the Coronavirus: Everything you need to know. This is a special edition of the PharmEZ Tutor spotlighting the new drug remdesivir, an antiviral for the treatment of COVID-19. Remdesivir is an antiviral drug and the first drug to be approved by the FDA to treat COVID-19 infections caused by the coronavirus 2 (SARS-CoV-2). This is a concise review that hopefully will provide the healthcare professional with useful information. REMDESIVIR UPDATES AND LINKS: December 11, 2020: New England Journal of Medicine published study: Baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. https://www.nejm.org/doi/full/10.1056... November 19, 2020: FDA Emergency Use Authorization (EUA) for the drug baricitinib in combination with remdesivir for treatment of COVID-19: https://www.fda.gov/news-events/press... ------------------------------------------------------------------------------------------------------------------------------------------------------ October 22, 2020: The FDA Emergency Use Authorization (EUA) to permit the emergency use of remdesivir for COVID-19 in other hospitalized pediatric patients. https://www.fda.gov/media/137566/down... October 22, 2020: Clarification from Gilead regarding pediatric use products. https://www.gilead.com/-/media/files/... October 15, 2020: World Health Organization’s SOLIDARITY trial (online on the preprint server Oct 2020- not peer reviewed) https://www.who.int/emergencies/disea... July 10, 2020: Additional data on the Simple severe Study https://www.gilead.com/news-and-press...